FDA sends 100 cease-and-desist letters in crackdown on DTC drug advertisements

The U.S. Food and Drug Administration is taking new steps to regulate direct-to-consumer drug advertisements and eliminate misleading advertisements out of concern that patients are not receiving a “fair balance” of information on pharmaceutical products.